bluebird bio Inc (BLUE.OQ)
BLUE.OQ on NASDAQ Stock Exchange Global Select Market
158.35USD
7:05pm BST
158.35USD
7:05pm BST
Change (% chg)
$2.15 (+1.38%)
$2.15 (+1.38%)
Prev Close
$156.20
$156.20
Open
$156.60
$156.60
Day's High
$158.35
$158.35
Day's Low
$154.85
$154.85
Volume
45,295
45,295
Avg. Vol
243,075
243,075
52-wk High
$236.05
$236.05
52-wk Low
$90.75
$90.75
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -2.82 | December | 17 Aug 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 5 | 6 | 6 | 6 |
| (2) OUTPERFORM | 9 | 9 | 7 | 6 |
| (3) HOLD | 6 | 6 | 7 | 7 |
| (4) UNDERPERFORM | 1 | 1 | 1 | 1 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.14 | 2.09 | 2.14 | 2.15 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 14 | 8.08 | 15.00 | 3.70 | 5.35 |
| Quarter Ending Dec-18 | 14 | 8.31 | 15.00 | 5.00 | 5.39 |
| Year Ending Dec-18 | 18 | 40.56 | 53.80 | 32.80 | 28.30 |
| Year Ending Dec-19 | 20 | 87.84 | 537.17 | 11.00 | 94.43 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 16 | -2.82 | -2.42 | -3.04 | -1.61 |
| Quarter Ending Dec-18 | 16 | -2.87 | -2.42 | -3.19 | -1.54 |
| Year Ending Dec-18 | 18 | -10.81 | -9.36 | -11.45 | -6.86 |
| Year Ending Dec-19 | 20 | -10.80 | -1.01 | -13.79 | -6.43 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Jun-18 | 9.64 | 7.85 | 1.79 | 18.58 |
| Quarter Ending Mar-18 | 5.60 | 15.96 | 10.36 | 185.11 |
| Quarter Ending Dec-17 | 7.06 | 4.17 | 2.89 | 40.93 |
| Quarter Ending Sep-17 | 7.07 | 7.71 | 0.64 | 9.06 |
| Quarter Ending Jun-17 | 5.21 | 16.72 | 11.51 | 220.88 |
| Earnings (per share) | ||||
| Quarter Ending Jun-18 | -2.35 | -2.91 | 0.56 | -24.01 |
| Quarter Ending Mar-18 | -2.07 | -2.31 | 0.24 | -11.70 |
| Quarter Ending Dec-17 | -1.70 | -2.52 | 0.82 | -48.14 |
| Quarter Ending Sep-17 | -1.71 | -1.73 | 0.02 | -1.38 |
| Quarter Ending Jun-17 | -1.65 | -1.73 | 0.08 | -4.56 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 8.08 | 8.08 | 9.05 | 8.62 | 5.35 |
| Quarter Ending Dec-18 | 8.31 | 8.31 | 9.14 | 8.69 | 5.39 |
| Year Ending Dec-18 | 40.56 | 40.56 | 40.85 | 38.99 | 28.30 |
| Year Ending Dec-19 | 87.84 | 87.84 | 87.36 | 86.87 | 94.43 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | -2.82 | -2.82 | -2.39 | -2.38 | -1.61 |
| Quarter Ending Dec-18 | -2.87 | -2.87 | -2.40 | -2.40 | -1.54 |
| Year Ending Dec-18 | -10.81 | -10.81 | -9.40 | -9.35 | -6.86 |
| Year Ending Dec-19 | -10.80 | -10.80 | -9.41 | -9.15 | -6.43 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-18 | 0 | 0 | 1 | 6 |
| Quarter Ending Dec-18 | 0 | 0 | 2 | 5 |
| Year Ending Dec-18 | 0 | 0 | 4 | 12 |
| Year Ending Dec-19 | 0 | 0 | 4 | 7 |
| Earnings | ||||
| Quarter Ending Sep-18 | 0 | 0 | 1 | 15 |
| Quarter Ending Dec-18 | 0 | 0 | 1 | 15 |
| Year Ending Dec-18 | 0 | 0 | 0 | 17 |
| Year Ending Dec-19 | 0 | 0 | 4 | 14 |
Earnings vs. 
Estimates- Express Scripts staking out million dollar gene therapies
- CORRECTED--Express Scripts staking out million dollar gene therapies
- RPT-FOCUS-Express Scripts staking out million dollar gene therapies
- Express Scripts staking out million-dollar gene therapies
- Express Scripts staking out million-dollar gene therapies